Literature DB >> 8281634

Low iron-binding capacity as a risk factor for myocardial infarction.

M K Magnusson1, N Sigfusson, H Sigvaldason, G M Johannesson, S Magnusson, G Thorgeirsson.   

Abstract

BACKGROUND: In a recent Finnish study, ferritin was suggested to be an independent risk factor for acute myocardial infarction. This study suggested that high levels of iron stores might thus be atherogenic and possibly explain partly the sex difference in the incidence of ischemic heart disease. METHODS AND
RESULTS: A randomly selected group (n = 2036), men and women aged 25 to 74 years, were examined between June and September 1983. All classic risk factors for coronary artery disease were measured as well as basic hematologic parameters and the parameters of iron metabolism, ie, iron, total iron-binding capacity (TIBC), and ferritin. During the follow-up for 8.5 years, 81 subjects experienced acute myocardial infarction (63 men and 18 women). The differences in the iron parameters between men and women were almost exclusively seen in ferritin values (198 micrograms/L in men and 91 micrograms/L in women), whereas small differences were seen in TIBC. The Cox proportional hazards model was used to estimate the contribution of independent variables to the risk of myocardial infarction. TIBC was found to be a strong independent negative risk factor in men (RR = 0.95; 95% CI, 0.92 to 0.98), whereas ferritin (RR = 0.999; 95% CI, 0.997 to 1.001) or other iron parameters had no significant predictive power. Each increase in TIBC of 1 mumol/L was associated with a 5.1% decrease in the risk of myocardial infarction. The classic major risk factors, ie, blood pressure, smoking, total cholesterol, and high-density lipoprotein, had significant independent correlation with myocardial infarction. When Cox multivariate analysis was carried out on both sexes combined, TIBC was still an independent negative risk factor, and the logarithmic transform of ferritin had a weak negative correlation but was not statistically significant. Sex was in this group still a very strong risk factor after taking into account all classic risk factors as well as the parameters of iron metabolism.
CONCLUSIONS: This study suggests that transferrin, measured as TIBC, is an independent negative risk factor for myocardial infarction. Other parameters of iron metabolism, including ferritin, were not found to contribute to the risk.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8281634     DOI: 10.1161/01.cir.89.1.102

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Excessive body iron stores are not associated with risk of coronary heart disease in women.

Authors:  Qi Sun; Jing Ma; Nader Rifai; Oscar H Franco; Kathryn M Rexrode; Frank B Hu
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

Review 2.  Iron deficiency and cardiovascular disease: an updated review of the evidence.

Authors:  Emanuela Lapice; Maria Masulli; Olga Vaccaro
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

3.  Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies.

Authors:  Jacob Hunnicutt; Ka He; Pengcheng Xun
Journal:  J Nutr       Date:  2014-01-08       Impact factor: 4.798

4.  Is increased tissue ferritin a risk factor for atherosclerosis and ischaemic heart disease?

Authors:  J F Koster; W Sluiter
Journal:  Br Heart J       Date:  1995-03

Review 5.  New concepts regarding events that lead to myocardial infarction.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

6.  Disordered vascular compliance in haemochromatosis.

Authors:  W J Cash; S O'Neill; M E O'Donnell; D R McCance; I S Young; J McEneny; I S Cadden; Neil I McDougall; M E Callender
Journal:  Ir J Med Sci       Date:  2013-09-03       Impact factor: 1.568

7.  Iron status is associated with carotid atherosclerotic plaques in middle-aged adults.

Authors:  Namanjeet Ahluwalia; Annelise Genoux; Jean Ferrieres; Bertrand Perret; Marion Carayol; Ludovic Drouet; Jean-Bernard Ruidavets
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

8.  Serum ferritin levels associated with increased risk for developing CHD in a low-income urban population.

Authors:  Meghan E Olesnevich; Marie Fanelli Kuczmarski; Marc Mason; Chengshun Fang; Alan B Zonderman; Michele K Evans
Journal:  Public Health Nutr       Date:  2012-01-10       Impact factor: 4.022

Review 9.  Safety aspects of parenteral iron in patients with end-stage renal disease.

Authors:  G Sunder-Plassmann; W H Hörl
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.606

10.  Iron deficiency in whole blood donors.

Authors:  Gary M Brittenham
Journal:  Transfusion       Date:  2011-03       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.